Benefits and Barriers to mHealth in Hypertension Care: Qualitative Study With German Health Care Professionals
Open Access
- 10 March 2025
- journal article
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 12, e52544
Abstract
Background: Digital health technologies, particularly mobile health (mHealth) apps and wearable devices, have emerged as crucial assets in the battle against hypertension. By enabling lifestyle modifications, facilitating home blood pressure monitoring, and promoting treatment adherence, these technologies have significantly enhanced hypertension treatment. Objective: This study aims to explore the perspectives of health care professionals (HCPs) regarding the perceived benefits and barriers associated with the integration of mHealth apps into routine hypertension care. Additionally, strategies for overcoming these barriers will be identified. Methods: Through qualitative analysis via semistructured interviews, general practitioners (n=10), cardiologists (n=14), and nurses (n=3) were purposefully selected between October 2022 and March 2023. Verbatim transcripts were analyzed using qualitative content analysis. Results: The results unveiled 3 overarching themes highlighting the benefits of mHealth apps in hypertension care from the perspective of HCPs. First, these technologies possess the potential to enhance patient safety by facilitating continuous monitoring and early detection of abnormalities. Second, they can empower patients, fostering autonomy in managing their health conditions, thereby promoting active participation in their care. Lastly, mHealth apps may provide valuable support to medical care by offering real-time data that aids in decision-making and treatment adjustments. Despite these benefits, the study identified several barriers hindering the seamless integration of mHealth apps into hypertension care. Challenges predominantly revolved around data management, communication contexts, daily routines, and system handling. HCPs underscored the necessity for structural and procedural modifications in their daily practices to effectively address these challenges. Conclusions: In conclusion, the effective usage of digital tools such as mHealth apps necessitates overcoming various obstacles. This entails meeting the information needs of both HCPs and patients, tackling interoperability issues to ensure seamless data exchange between different systems, clarifying uncertainties surrounding reimbursement policies, and establishing the specific clinical benefits of these technologies. Active engagement of users throughout the design and implementation phases is crucial for ensuring the usability and acceptance of mHealth apps. Moreover, enhancing knowledge accessibility through the provision of easily understandable information about mHealth apps is essential for eliminating barriers and fostering their widespread adoption in hypertension care. Trial Registration: German Clinical Trials Register DRKS00029761; https://drks.de/search/de/trial/DRKS00029761 International Registered Report Identifier (IRRID): RR2-10.3389/fcvm.2022.1089968Keywords
All Related Versions
This publication has 26 references indexed in Scilit:
- Professionelle Gesundheitskompetenz von Hausärzt:innen – Ergebnisse des HLS-PROFDas Gesundheitswesen, 2024
- Patients' perspectives on digital health toolsPEC Innovation, 2023
- Real-world usage of digital health applications (DiGA) in rheumatology: results from a German patient surveyRheumatology International, 2022
- Digitally supported shared decision-making and treat-to-target in rheumatology: a qualitative study embedded in a multicenter randomized controlled trialRheumatology International, 2022
- New perspectives for hypertension management: progress in methodological and technological developmentsEuropean Journal of Preventive Cardiology, 2022
- Mobile Health Applications and Medication Adherence of Patients With Hypertension: A Systematic Review and Meta-AnalysisAmerican Journal of Preventive Medicine, 2022
- Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertensionNature Reviews Cardiology, 2021
- The influence of mobile health applications on patient - healthcare provider relationships: A systematic, narrative reviewPatient Education and Counseling, 2019
- Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015JAMA, 2017
- A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertensionThe Lancet, 2016